177 related articles for article (PubMed ID: 27760342)
1. Antiviral CD8
Ranasinghe S; Lamothe PA; Soghoian DZ; Kazer SW; Cole MB; Shalek AK; Yosef N; Jones RB; Donaghey F; Nwonu C; Jani P; Clayton GM; Crawford F; White J; Montoya A; Power K; Allen TM; Streeck H; Kaufmann DE; Picker LJ; Kappler JW; Walker BD
Immunity; 2016 Oct; 45(4):917-930. PubMed ID: 27760342
[TBL] [Abstract][Full Text] [Related]
2. HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
Nyanhete TE; Frisbee AL; Bradley T; Faison WJ; Robins E; Payne T; Freel SA; Sawant S; Weinhold KJ; Wiehe K; Haynes BF; Ferrari G; Li QJ; Moody MA; Tomaras GD
Sci Rep; 2019 Jul; 9(1):10165. PubMed ID: 31308388
[TBL] [Abstract][Full Text] [Related]
3. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
[TBL] [Abstract][Full Text] [Related]
4. HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment.
Ueno T; Tomiyama H; Fujiwara M; Oka S; Takiguchi M
Eur J Immunol; 2003 Oct; 33(10):2910-6. PubMed ID: 14515275
[TBL] [Abstract][Full Text] [Related]
5. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
6. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
Erb K; Blank C; Ritter U; Bluethmann H; Moll H
Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
[TBL] [Abstract][Full Text] [Related]
7. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
8. HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication.
Mackewicz CE; Garovoy MR; Levy JA
J Virol; 1998 Dec; 72(12):10165-70. PubMed ID: 9811757
[TBL] [Abstract][Full Text] [Related]
9. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1.
Jiang H; Chess L
Annu Rev Immunol; 2000; 18():185-216. PubMed ID: 10837057
[TBL] [Abstract][Full Text] [Related]
10. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
Bot A; Casares S; Bot S; von Boehmer H; Bona C
J Immunol; 1998 May; 160(9):4500-7. PubMed ID: 9574556
[TBL] [Abstract][Full Text] [Related]
11. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
[TBL] [Abstract][Full Text] [Related]
13. Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells.
Braaten DC; McClellan JS; Messaoudi I; Tibbetts SA; McClellan KB; Nikolich-Zugich J; Virgin HW
PLoS Pathog; 2006 May; 2(5):e37. PubMed ID: 16733540
[TBL] [Abstract][Full Text] [Related]
14. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
[TBL] [Abstract][Full Text] [Related]
16. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
17. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells.
Tyznik AJ; Sun JC; Bevan MJ
J Exp Med; 2004 Feb; 199(4):559-65. PubMed ID: 14769854
[TBL] [Abstract][Full Text] [Related]
18. Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.
Reguzova AY; Karpenko LI; Mechetina LV; Belyakov IM
Expert Rev Vaccines; 2015 Jan; 14(1):69-84. PubMed ID: 25373312
[TBL] [Abstract][Full Text] [Related]
19. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene.
Bour H; Peyron E; Gaucherand M; Garrigue JL; Desvignes C; Kaiserlian D; Revillard JP; Nicolas JF
Eur J Immunol; 1995 Nov; 25(11):3006-10. PubMed ID: 7489735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
